COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Study of the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Antitumor Activity of KN046 in Subjects With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03529526
Recruitment Status : Unknown
Verified May 2018 by Alphamab (Australia) Co Pty Ltd..
Recruitment status was:  Recruiting
First Posted : May 18, 2018
Last Update Posted : May 22, 2018
Information provided by (Responsible Party):
Alphamab (Australia) Co Pty Ltd.

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : October 30, 2019
Estimated Study Completion Date : March 30, 2020